大肠杆菌对结直肠癌的影响:双刃剑
Chu Jian1,2,3, Wu Yinhang1,2,3, Zhuang Jing1,2,3
1Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, Huzhou, Zhejiang, People's Republic of China.
Microbial biotechnology
|October 14, 2024
概括
大肠杆菌 (E. coli) 在结肠直肠癌 (CRC) 中具有双重作用. 大肠杆菌的变异可以作为CRC查的生物标志物,而工程菌株显示CRC治疗的潜力.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 生物技术是生物技术.
背景情况:
- 大肠杆菌 (E. coli) 是一种常见的肠道细菌,具有多种功能.
- 肠道微生物组在结直肠癌 (CRC) 中的作用是复杂的,并未完全理解.
- 大肠杆菌的矛盾性质在CRC管理中带来了机遇和挑战.
研究的目的:
- 探索大肠杆菌在结肠直肠癌 (CRC) 中的"双刃剑"理论.
- 调查大肠杆菌作为CRC查生物标志物的潜力.
- 评估大肠杆菌在CRC治疗中的作用,包括工程菌株.
主要方法:
- 对大肠杆菌和CRC现有文献的审查.
- 分析大肠杆菌的丰度和亚型作为潜在的生物标志物.
- 工程化大肠杆菌和合成生物学用于治疗应用的探索.
- 考虑对大肠杆菌应用的"一个健康"视角.
主要成果:
- 大肠杆菌变异可以作为CRC查的生物标志物.
- 工程化大肠杆菌,特别是益生菌亚型,显示出CRC治疗的希望.
- 大肠杆菌的主要治疗价值可能在于它被用作与其他技术集成的研究平台.
- 肠道微生物组内的复杂相互作用需要采用整体方法.
结论:
- 大肠杆菌在CRC中表现出"双刃剑"的作用,为查和治疗提供了潜力.
- 利用大肠杆菌用于CRC需要了解其多样化的功能和相互作用.
- 未来的应用应将大肠杆菌与先进技术相结合,并考虑"一健康"框架.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...


